When Abilify was first approved for the treatment of schizophrenia in 2002, it was touted as an effective new option to treat serious mental illness. What users of the antipsychotic medication did not realize was that Abilify had hidden side effects that could change their lives forever.
Users allege that taking Abilify caused them to develop compulsive behaviors, including binge eating, hypersexuality, and pathological gambling. After several studies and dozens of reports confirmed a link between the drug and compulsive behavior, regulators around the world took aim at the drug. Now, hundreds of people have filed lawsuits against drugmakers Otsuka Pharmaceutical Co. and Bristol-Myers Squibb Company over claims that they knew about the side effects but did nothing to warn consumers.